Stemlogix Selects Butler Schein Animal Health Health to Distribute Versatile In-Clinic Stem Cell Therapy System to Veterinarians

Published: Apr 17, 2012

WESTON, Fla., April 17, 2012 (GLOBE NEWSWIRE) -- Stemlogix, a regenerative medicine company offering premier in-clinic stem cell therapy solutions to veterinarians, announced today that it has selected Butler Schein Animal Healthâ„¢ to distribute its regenerative medicine system, stem cell therapy kits and other biological therapies. Butler Schein Animal Healthâ„¢ - a Henry Schein Company - is the largest companion animal health distribution company in the U.S.

Back to news